Rare diseases
Investigational molecules
Locations
453 conditions with trials, the busiest first
1 389 trials across Europe, recruiting first
Study on Carisbamate for Treating Seizures in Children and Adults with Lennox-Gastaut Syndrome
GermanyStudy on the Long-Term Safety of Rimegepant for Treating Acute Migraine in Children and Adolescents Aged 6 to 17 Years
PolandStudy on Dinutuximab Beta with Chemotherapy for Children and Teens with Newly Diagnosed High-Risk Neuroblastoma
AustriaStudy of AZD9574 and Temozolomide for Patients with Advanced Solid Tumors, Including Breast, Ovarian, Pancreatic, and Prostate Cancers
SpainStudy on the Effects of Metformin for Improving Muscle Function in Patients with Myotonic Dystrophy Type 1
FranceStudy on Efgartigimod for Children Aged 2-17 with Generalized Myasthenia Gravis
BelgiumStudy on the Effects of Iptacopan in Patients with Generalized Myasthenia Gravis
DenmarkStudy on Bortezomib for Patients with Severe Autoimmune Encephalitis
GermanyStudy on the Effectiveness of Methylphenidate for Children and Adolescents with KBG Syndrome
The NetherlandsStudy on the Effects of Ozanimod in Patients with Relapsing-Remitting Multiple Sclerosis
ItalyStudy on the Safety of CA-4948 and Ibrutinib for Patients with Relapsed or Refractory Primary Central Nervous System Lymphoma
CzechiaStudy on ATX-01 for Adults Aged 18-64 with Myotonic Dystrophy Type 1 (DM1)
FranceThe therapies tested most often in Nervous system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
